Pulmonary fibrosis is the end stage of a broad range of heterogeneous interstitial lung
diseases and more than 200 factors contribute to it. In recent years, the relationship between …

Since the initial identification of the novel coronavirus SARS-CoV-2 in December 2019, the
COVID-19 pandemic has become a leading cause of morbidity and mortality worldwide. As …

Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …

METHODS Electronic databases, including PubMed, EMBASE, Cochrane Library, Science
Direct, Google Scholar, were systematically searched from the initiation of the database until …

The transfer of mitochondria between cells has recently been revealed as a spontaneous
way to protect the injured cells. However, the utilization of this natural transfer process for …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
coronavirus disease (COVID-19), a highly contagious infectious disease that has caused …

The pandemic brought on by the outbreak of severe acute respiratory syndrome coronavirus
2 (SARS-CoV2) has become a global health crisis, with over 22 million confirmed cases and …

COVID-19 is a highly contagious respiratory disease, which mainly affects the lungs.
Critically ill patients are easily complicated by cytokine storms, acute respiratory distress …

The costs of coronavirus disease 2019 (COVID-19) are devastating. With millions of deaths
worldwide, specific serological biomarkers, antiviral agents, and novel therapies are …

Purpose Pulmonary fibrosis caused by COVID-19 pneumonia is a serious complication of
COVID-19 infection, there is a lack of effective treatment methods clinically. This article …